What's new in Kawasaki disease?

Article

Revised guidelines help evaluate the child who doesn't meet all the classic criteria for KD and provide a framework for long-term management based on the risk of myocardial infarction.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
John Browning, MD, provides practical skincare reminders ahead of summer season
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Related Content
Long sleep duration after acute concussion in youths associated with more symptoms later | Image Credit: © Viacheslav Yakobchuk - © Viacheslav Yakobchuk - stock.adobe.com.

Long sleep duration after acute concussion in youths associated with more symptoms later

Joshua Fitch, Senior Editor
July 2nd 2025
Article

Additionally, long sleep duration could be associated with increased odds of being reliably symptomatic at 4 weeks.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
Top 5 pediatric health headlines you missed in June 2025 | Image Credit: © sebra - stock.adobe.com.

Top 5 pediatric health headlines you missed in June 2025

Morgan Ebert, Managing Editor
July 2nd 2025
Article

Take a quick look at everything you may have missed last month, including the top FDA approvals and latest clinical updates.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
© Contemporary Pediatrics

FDA news in pediatrics: June 2025

Morgan Ebert, Managing Editor
July 1st 2025
Article

A look back at the FDA submissions and regulatory decisions in the pediatric health care space from June 2025.

FDA notifies providers of safety-related changes to prescribing information of maralixibat, odevixibat | Image Credit: Contemporary Pediatrics

FDA notifies providers of safety-related changes to prescribing information of maralixibat, odevixibat

Joshua Fitch, Senior Editor
June 30th 2025
Article

The updated labeling includes a new contraindication for patients with prior or active hepatic events.

© 2025 MJH Life Sciences

All rights reserved.